Zhongyi Sun

Mar 5, 2024 | ascpt.onlinelibrary.wiley.com | Lu Liu |Kun Wang |Ltd. Shanghai |Zhongyi Sun

WHAT IS THE CURRENT KNOWLEDGE ON THE TOPIC? Ciprofol is a highly selective GABAA receptor potentiator that is about four to five times more potent than propofol and has fewer adverse events. WHAT QUESTION DID THIS STUDY ADDRESS? What are the potential intrinsic and extrinsic covariates that can impact the pharmacokinetics (PKs) of ciprofol? Is the approved ciprofol dose regimen for mechanically ventilated patients in the intensive care unit (ICU) well-tolerated and safe?

Dec 18, 2023 | mdpi.com | Zhongyi Sun |Hongyan Lu |Yi Ren |Hongshan Shi

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.